Trending
- Managing Brain Metastases in HER2-Mutant NSCLC
- Relapsed/Refractory Multiple Myeloma: Debate — Contextualizing Safety and Sequencing BCMA-Directed Therapies
- Relapsed/Refractory Multiple Myeloma: Case-Based Discussion — Rapidly Progressive Earlier-Relapse Disease
- Relapsed/Refractory Multiple Myeloma: Case-Based Discussion — The Fit, Immunotherapy-Eligible Patient in Second Line
- Elevated serum HBcrAg and earlier onset of hepatocellular carcinoma in chronic hepatitis B
- <![CDATA[Relapsed/Refractory Multiple Myeloma: Case-Based Discussion — The Comorbid, Higher-Risk Patient, and Program Conclusions]]>
- CARTITUDE-2 Cohort A Follow-Up Data and Preparing Patients for CAR TCell Therapy
- Follow-Up After a One-Time Therapy and Shared Care With Community Practices
Thursday, October 1